InterCure InterCure saw its stock jump nearly 10% after releasing its third quarter financial results on Tuesday, November 15.
INTERCURE has released another set of ‘all time record quarterly’ results, seeing both revenues and profits skyrocket year-on-year.
INTERCURE Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) and Clever Leaves Holdings Inc.
AS European Cannabis stocks continue their battle against external market forces, it has been internal battles which made the headlines this week.
Israel’s largest licensed cannabis producer Intercure has announced plans to acquire medical cannabis operator Better for $35m, sending its share prices spiking over 5% for the second time in a week.
As markets across Europe continue to be hammered by international tensions, gas price increases and a looming cost of living crisis, cannabis stocks largely struggled to make any significant gains.
INTERCURE, which calls itself the ‘most profitable and fastest growing’ cannabis company outside of North America, is poised to open a number of cannabis shops on UK high streets.
InterCure Ltd. today announced its international expansion into Europe through a partnership with iconic cannabis brand Cookies.
INTERCURE is predicting revenues of C$100m (£59m) over the coming year after reporting record sales in its third quarter.
